Carmel Capital Partners, LLC Johnson & Johnson Transaction History

Carmel Capital Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$155.75 - $174.48 $43,142 - $48,330	277 Added 22.02%	1,535 $239,000
Q2 2023 Jul 27, 2023	SELL	$154.35 - $166.11 $87,516 - $94,184	-567 Reduced 31.07%	1,258 $208,000
Q1 2023 Apr 19, 2023	SELL	$151.05 - $180.26 $29,454 - $35,150	-195 Reduced 9.65%	1,825 $282,000
Q4 2022 Jan 17, 2023	BUY	$160.2 - $179.79 $68,085 - $76,410	425 Added 26.65%	2,020 $0
Q2 2022 Jul 11, 2022	BUY	$168.19 - $186.01 $42,047 - $46,502	250 Added 18.59%	1,595 $283,000
Q1 2022 Apr 18, 2022	SELL	$158.14 - $179.59 $6,325 - $7,183	-40 Reduced 2.89%	1,345 $238,000
Q4 2021 Jan 31, 2022	BUY	$155.93 - $173.01 $215,963 - $239,618	1,385 New	1,385 $237,000

4,275

1.68B

17.6M

14.5M

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $381B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

Get notified when there are updates to the investment portfolio of Carmel Capital Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Carmel Capital Partners, LLC with notifications on news.